BPS804, an anti-sclerostin monoclonal antibody, improves disease biomarkers and markers of bone formation in patients with adult-onset hypophosphatasia (HPP)
JOURNAL OF BONE AND MINERAL RESEARCH(2013)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要